NTRA Stock: Price, Earnings History and SEC Filings
Natera, Inc. (NTRA) last traded at $414.30, down 4.98% on the latest session and up 0.2% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $-0.47 against an analyst estimate of $-0.47, a beat of 0.0%.
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
NTRA earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | Aug 6, 2026 | $-0.47 | $-0.47 | +0.00% |
| Mar 2026 | May 7, 2026 | $-0.56 | $-0.53 | -5.66% |
| Dec 2025 | Feb 26, 2026 | $0.35 | $-0.46 | +176.09% |
| Sep 2025 | Nov 6, 2025 | $-0.64 | $-0.39 | -64.10% |
NTRA beat the analyst EPS estimate in 1 of its last 4 reported quarters. Source: Nasdaq.
How NTRA reacts to earnings
Across its last 8 earnings releases, NTRA moved 6.7% on average the next session, in either direction. It rose after 4 of 8 reports.
| Report date | Released | Next-session move |
|---|---|---|
| 2026-08-06 | After close | +21.37% |
| 2026-05-07 | After close | -11.64% |
| 2026-02-26 | After close | -3.73% |
| 2026-01-12 | After close | +1.04% |
| 2025-11-06 | After close | +0.55% |
| 2025-08-07 | After close | +7.70% |
| 2025-05-08 | After close | -6.53% |
| 2025-02-27 | After close | -0.65% |
Based on the dates of earnings-release 8-K filings (SEC EDGAR) and daily closing prices (Yahoo Finance). Past reactions do not predict future ones.
NTRA financial history
| Fiscal year | Revenue | Net income | Free cash flow | Net margin | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | $2.3B | -$208M | $109M | -9.0% | $-1.52 |
| 2024 | $1.7B | -$190M | $69M | -11.2% | $-1.53 |
| 2023 | $1.1B | -$435M | -$286M | -40.2% | $-3.78 |
| 2022 | $820M | -$548M | -$479M | -66.8% | $-5.57 |
| 2021 | $625M | -$472M | -$376M | -75.4% | $-5.21 |
| 2020 | $391M | -$230M | -$202M | -58.8% | $-2.84 |
| 2019 | $302M | -$125M | -$68M | -41.3% | $-1.79 |
| 2018 | $258M | -$128M | -$74M | -49.7% | $-2.22 |
Source: annual figures from 10-K filings on SEC EDGAR. The year shown is the calendar year the fiscal year ended. Free cash flow is operating cash flow minus capital spending.
Latest SEC filings for NTRA
- 10-Q · Aug 7, 2026
- 8-K · Aug 6, 2026Results of operations, Financial statements and exhibits
- 8-K · Jul 6, 2026Officer or director change
- 8-K · Jun 16, 2026Officer or director change, Shareholder vote, Financial statements and exhibits
- 8-K · Jun 5, 2026Officer or director change, Financial statements and exhibits
- 10-Q · May 8, 2026
- 8-K · May 7, 2026Results of operations, Financial statements and exhibits
- DEF 14A · Apr 23, 2026
- 8-K · Apr 1, 2026Officer or director change, Financial statements and exhibits
- 10-K · Feb 27, 2026
Insider filing activity
NTRA insiders filed 32 Form 4 reports in the last 90 days. A Form 4 is how directors and executives disclose purchases, sales and grants of company stock. See the individual filings on SEC EDGAR. Many Form 4 filings are routine, such as scheduled sales or option exercises, so check each filing before drawing a conclusion.
Source: SEC EDGAR.
NTRA news
- CareDx Soars 20% on Big Q3 Beat and Guidance RaiseOct 30, 2026 · tikr.com
- When The Stock Market Is Choppy, It Pays To Watch This Technical SetupOct 30, 2026 · finance.yahoo.com
- Global Genetic Counseling Services Market Report 2026 | Capitalize on AI and Telehealth as Market Hits $4.67 Billion by 2030: Labcorp, Quest Diagnostics, Natera, GeneDxOct 30, 2026 · finance.yahoo.com
- Illumina Sinks 13% on Light Q3 Revenue Despite EPS Beat and Raised GuidanceOct 30, 2026 · tikr.com
- CareDx (CDNA) Surpasses Q3 Earnings and Revenue EstimatesOct 29, 2026 · finance.yahoo.com
- Global Pan-Ethnic Carrier Screening Programs Market Report 2026 | Capitalize on 14.1% CAGR as Illumina, Natera, Fulgent Genetics and LabCorp Scale AI and Multi-Gene PanelsOct 29, 2026 · finance.yahoo.com
- Natera (NTRA) May Report Negative Earnings: Know the Trend Ahead of Q3 ReleaseOct 29, 2026 · finance.yahoo.com
- Natera to Report its Third Quarter Results on November 5, 2026Oct 29, 2026 · finance.yahoo.com
About Natera, Inc.
Natera, Inc. (NTRA) is a US-listed public company on Nasdaq. The SEC classifies its business as Services-medical Laboratories. It is incorporated in DE. Its fiscal year ends in December.